Lung cancer and human papilloma viruses (HPVs): Examining the molecular evidence

Journal of Oncology

Volumn , Issue , 2012, Pages

  Prabhu, Priya R ^a   Jayalekshmi, D ^a   Pillai, M Radhakrishna ^a  

^a RAJIV GANDHI CENTRE FOR BIOTECHNOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 CHLORO 4 IODOANILINO) N CYCLOPROPYLMETHOXY 3,4 DIFLUOROBENZAMIDE; ALPHA6BETA4 INTEGRIN; ANTINEOPLASTIC AGENT; APOPTOSIS INHIBITOR; CARBOPLATIN; CETUXIMAB; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FRAGILE HISTIDINE TRIAD PROTEIN; FULVESTRANT; GEFITINIB; HYPOXIA INDUCIBLE FACTOR; K RAS PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; MATUZUMAB; PACLITAXEL; PROTEIN BAK; PROTEIN BCL 2; PROTEIN E6; PROTEIN E7; PROTEIN P53; PROTEIN TYROSINE KINASE INHIBITOR; RAPAMYCIN; RETINOBLASTOMA PROTEIN; TEMSIROLIMUS; VIRUS DNA; WART VIRUS VACCINE;

ADVANCED CANCER; ANTINEOPLASTIC ACTIVITY; CANCER COMBINATION CHEMOTHERAPY; CANCER IMMUNIZATION; CANCER IMMUNOTHERAPY; CANCER TISSUE; CONDYLOMA ACUMINATUM; DISEASE ASSOCIATION; GENE EXPRESSION REGULATION; GENE MUTATION; GENETIC HETEROGENEITY; GEOGRAPHIC DISTRIBUTION; HETEROGENEITY LOSS; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; INCIDENCE; INTERNALIZATION; LUNG CANCER; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; NONHUMAN; PREVALENCE; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REVIEW; SEX DIFFERENCE; SEXUAL TRANSMISSION; UPREGULATION; UTERINE CERVIX CANCER; VIRUS CARCINOGENESIS; VIRUS ENTRY; VIRUS GENOME; VIRUS TRANSMISSION; WART VIRUS;

EID: 84858242106     PISSN: 16878450     EISSN: 16878469     Source Type: Journal    
DOI: 10.1155/2012/750270     Document Type: Review

References (64)

1. Parkin D. M., Bray F., Ferlay J., Pisani P., Global cancer statistics, 2002 Ca: A Cancer Journal for Clinicians 2005 55 2 74 108 (Pubitemid 40372904)
2. Syrjnen K. J., Condylomatous changes in neoplastic bronchial epithelium. Report of a case Respiration 1979 38 5 299 304
3. Pillai M. R., Phanidhara A., Kesari A. L., Nair P., Nair M. K., Cellular manifestations of human papillomavirus infection in the oral mucosa Journal of Surgical Oncology 1999 71 1 10 15 (Pubitemid 29244904)
4. Jacob S. E., Sreevidya S., Chacko E., Pillai M. R., Cellular manifestations of human papilloma virus infection in laryngeal tissues Journal of Surgical Oncology 2002 79 142 150
5. Pillai M. R., Nair M. K., Development of a condemned mucosa syndrome and pathogenesis of human papillomavirus-associated upper aerodigestive tract and uterine cervical tumors Experimental and Molecular Pathology 2000 69 3 233 241 (Pubitemid 32006303)
6. Ferenczy A., Franco E., Persistent human papillomavirus infection and cervical neoplasia The Lancet Oncology 2002 3 1 11 16 (Pubitemid 34121141)
7. Gonzalez S. L., Stremlau M., He X., Basile J. R., Mnger K., Degradation of the retinoblastoma tumor suppressor by the human papillomavirus type 16 E7 oncoprotein is important for functional inactivation and is separable from proteasomal degradation of E7 Journal of Virology 2001 75 16 7583 7591 (Pubitemid 32738016)
8. Rogli M., Juki S., Damjanov I., Cytology of the solitary papilloma of the bronchus Acta Cytologica 1975 19 1 11 13
9. Rubel L. R., Reynolds R. E., Cytologic description of squamous cell papilloma of the respiratory tract Acta Cytologica 1979 23 3 227 230 (Pubitemid 9187555)
10. Klein F., Amin Kotb W. F. M., Petersen I., Incidence of human papilloma virus in lung cancer Lung Cancer 2009 65 1 13 18
11. Sun S., Schiller J. H., Gazdar A. F., Lung cancer in never smokersa different disease Nature Reviews Cancer 2007 7 10 778 790 (Pubitemid 47463669)
12. Smith E. M., Ritchie J. M., Summersgill K. F., Klussmann J. P., Lee J. H., Wang D., Haugen T. H., Turek L. P., Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers International Journal of Cancer 2004 108 5 766 772 (Pubitemid 38076410)
13. Rabkin C. S., Biggar R. J., Melbye M., Curtis R. E., Second primary cancers following anal and cervical carcinoma: evidence of shared etiologic factors American Journal of Epidemiology 1992 136 1 54 58
14. Hennig E. M., Sou Z., Karlsen F., Holm R., Thoresen S., Nesland J. M., HPV positive bronchopulmonary carcinomas in women with previous high-grade cervical intraepithelial neoplasia (CIN III) Acta Oncologica 1999 38 5 639 647 (Pubitemid 29333747)
15. Tseng C. J., Pao C. C., Lin J. D., Soong Y. K., Hong J. H., Hsueh S., Detection of human papillomavirus types 16 and 18 mRNA in peripheral blood of advanced cervical cancer patients and its association with prognosis Journal of Clinical Oncology 1999 17 5 1391 1396 (Pubitemid 29220844)
16. Cheng Y. W., Chiou H. L., Sheu G. T., Hsieh L. L., Chen J. T., Chen C. Y., Su J. M., Lee H., The association of human papillomavirus 16/18 infection with lung cancer among nonsmoking Taiwanese women Cancer Research 2001 61 7 2799 2803 (Pubitemid 32691913)
17. Chiou H. L., Wu M. F., Liaw Y. C., Cheng Y. W., Wong R. H., Chen C. Y., Lee H., The presence of human papillomavirus type 16/18 DNA in blood circulation may act as a risk marker of lung cancer in Taiwan Cancer 2003 97 6 1558 1563 (Pubitemid 36297786)
18. Bodaghi S., Wood L. V., Roby G., Ryder C., Steinberg S. M., Zheng Z. M., Could human papillomaviruses be spread through blood? Journal of Clinical Microbiology 2005 43 11 5428 5434 (Pubitemid 41612309)
19. Horvath C. A., Boulet G. A., Renoux V. M., Delvenne P. O., Bogers J. P. J., Mechanisms of cell entry by human papillomaviruses: an overview Virology Journal 2010 7, article 11
20. Giroglou T., Florin L., Schfer F., Streeck R. E., Sapp M., Human papillomavirus infection requires cell surface heparan sulfate Journal of Virology 2001 75 3 1565 1570 (Pubitemid 32094716)
21. Lories V., Cassiman J. J., Van den Berghe H., David G., Differential expression of cell surface heparan sulfate proteoglycans in human mammary epithelial cells and lung fibroblasts Journal of Biological Chemistry 1992 267 2 1116 1122
22. Heremans A., Cassiman J. J., van den Berghe H., David G., Heparan sulfate proteoglycan from the extracellular matrix of human lung fibroblasts. Isolation, purification, and core protein characterization Journal of Biological Chemistry 1988 263 10 4731 4739
23. Haupt L. M., Griffiths L. R., Heparan sulfate proteoglycans, tumour progression and the cancer stem cell niche Current Cancer Therapy Reviews 2009 5 4 256 260
24. Levina V., Marrangoni A. M., DeMarco R., Gorelik E., Lokshin A. E., Drug-selected human lung cancer stem cells: cytokine network, tumorigenic and metastatic properties PLoS One 2008 3 8
25. McQualter J. L., Yuen K., Williams B., Bertoncello I., Evidence of an epithelial stem/progenitor cell hierarchy in the adult mouse lung Proceedings of the National Academy of Sciences of the United States of America 2010 107 4 1414 1419
26. Letian T., Tianyu Z., Cellular receptor binding and entry of human papillomavirus Virology Journal 2010 7, article 2
27. Aguayo F., Castillo A., Koriyama C., Higashi M., Itoh T., Capetillo M., Shuyama K., Corvalan A., Eizuru Y., Akiba S., Human papillomavirus-16 is integrated in lung carcinomas: a study in Chile British Journal of Cancer 2007 97 1 85 91 (Pubitemid 47012101)
28. Cheng Y. W., Wu M. F., Wang J., Yeh K. T., Goan Y. G., Chiou H. L., Chen C. Y., Lee H., Human papillomavirus 16/18 E6 oncoprotein is expressed in lung cancer and related with p53 inactivation Cancer Research 2007 67 22 10686 10693 (Pubitemid 350145894)
29. Wang J., Cheng Y. W., Wu D. W., Chen J. T., Chen C. Y., Chou M. C., Lee H., Frequent FHIT gene loss of heterozygosity in human papillomavirus-infected non-smoking female lung cancer in Taiwan Cancer Letters 2006 235 1 18 25
30. Xu Y., Cheng B., Pan H., Wu A., Zhang L., The relationship between the status of human papillomavirus 16/18 infection and the expression of Bcl-2 and Bax in squamous cell carcinomas of the lung Chinese Journal of Lung Cancer 2009 12 8 849 852
31. Noutsou A., Koffa M., Ergasaki M., Siafakas N. M., Spandidos D. A., Detection of human papilloma virus and K-ras mutations in lung carcinomas International Journal of Oncology 1996 8 1089 1093 (Pubitemid 26178555)
32. Pan H., Griep A. E., Temporally distinct patterns of p53-dependent and p53-independent apoptosis during mouse lens development Genes and Development 1995 9 17 2157 2169
33. Pillai M. R., Halabi S., McKalip A., Jayaprakash P. G., Rajalekshmi T. N., Nair M. K., Herman B., The presence of human papillomavirus-16/-18 E6, p53, and bcl-2 protein in cervicovaginal smears from patients with invasive cervical cancer Cancer Epidemiology Biomarkers and Prevention 1996 5 5 329 335 (Pubitemid 26139114)
34. Kinoshita I., Dosaka-Akita H., Shindoh M., Fujino M., Akie K., Kato M., Fujinaga K., Kawakami Y., Human papillomavirus type 18 DNA and E6-E7 mRNA are detected in squamous cell carcinoma and adenocarcinoma of the lung British Journal of Cancer 1995 71 2 344 349
35. Wu D.-W., Liu W.-S., Wang J., Chen C.-Y., Cheng Y.-W., Lee H., Reduced p21WAF1/CIP1 via alteration of p53-DDX3 pathway is associated with poor relapse-free survival in early-stage human papillomavirus-associated lung cancer Clinical Cancer Research 2011 17 7 1895 1905
36. Wu H. H., Wu J. Y., Cheng Y. W., Chen C. Y., Lee M. C., Goan Y. G., Lee H., cIAP2 upregulated by E6 oncoprotein via epidermal growth factor receptor/phosphatidylinositol 3-kinase/AKT pathway confers resistance to cisplatin in human papillomavirus 16/18-infected lung cancer Clinical Cancer Research 2010 16 21 5200 5210
37. Thomas M., Banks L., Inhibition of Bak-induced apoptosis by HPV-18 E6 Oncogene 1998 17 23 2943 2954 (Pubitemid 29012197)
38. Wu M. F., Cheng Y. W., Lai J. C., Hsu M. C., Chen J. T., Liu W. S., Chiou M. C., Chen C. Y., Lee H., Frequent p16INK4a promoter hypermethylation in human papillomavirus-infected female lung cancer in Taiwan International Journal of Cancer 2005 113 3 440 445 (Pubitemid 40038712)
39. Lin T. S., Lee H., Chen R. A., Ho M. L., Lin C. Y., Chen Y. H., Tsai Y. Y., Chou M. C., Cheng Y. W., An association of DNMT3b protein expression with P16INK4a promoter hypermethylation in non-smoking female lung cancer with human papillomavirus infection Cancer Letters 2005 226 1 77 84 (Pubitemid 40943432)
40. DiMaio D., Mattoon D., Mechanisms of cell transformation by papillomavirus E5 proteins Oncogene 2001 20 54 7866 7873 (Pubitemid 33135313)
41. Zur Hausen H., De Villiers E. M., Human papillomaviruses Annual Review of Microbiology 1994 48 427 447 (Pubitemid 24334104)
42. Conrad M., Goldstein D., Andresson T., Schlegel R., The E5 protein of HPV-6, but not HPV-16, associates efficiently with cellular growth factor receptors Virology 1994 200 2 796 800 (Pubitemid 24146557)
43. Hwang E. S., Nottoli T., Dimaio D., The HPV16 E5 protein: expression, detection, and stable complex formation with transmembrane proteins in COS cells Virology 1995 211 1 227 233
44. Straight S. W., Hinkle P. M., Jewers R. J., McCance D. J., The E5 oncoprotein of human papilloma virus type 16 transforms fibroblasts and effects the down regulation of the epidermal growth factor receptor in keratinocytes Journal of Virology 1993 67 4521 4532 (Pubitemid 23215930)
45. Crusius K., Auvinen E., Steuer B., Gaissert H., Alonso A., The human papillomavirus type 16 E5-protein modulates ligand-dependent activation of the EGF receptor family in the human epithelial cell line HaCaT Experimental Cell Research 1998 241 1 76 83 (Pubitemid 28366581)
46. Chen S.-L., Huang C. H., Tsai T. C., Lu K. Y., Tsao Y. P., The regulation mechanism of c-jun and junB by human papillomavirus type 16 E5 oncoprotein Archives of Virology 1996 141 5 791 800 (Pubitemid 126706527)
47. Tsao Y. P., Li L. Y., Tsai T. C., Chen S. L., Human papillomavirus type 11 and 16 E5 represses p21WafI/SdiI/CipI gene expression in fibroblasts and keratinocytes Journal of Virology 1996 70 11 7535 7539
48. Crusius K., Rodriguez I., Alonso A., The human papillomavirus type 16 E5 protein modulates ERK1/2 and p38 MAP kinase activation by an EGFR-independent process in stressed human keratinocytes Virus Genes 2000 20 1 65 69 (Pubitemid 30168919)
49. Brake T., Lambert P. F., Estrogen contributes to the onset, persistence, and malignant progression of cervical cancer in a human papillomavirus- transgenic mouse model Proceedings of the National Academy of Sciences of the United States of America 2005 102 7 2490 2495 (Pubitemid 40279404)
50. Stabile L. P., Gaither Davis A. L., Gubish C. T., Hopkins T. M., Luketich J. D., Christie N., Finkelstein S., Siegfried J. M., Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor and and show biological responses to estrogen Cancer Research 2002 62 7 2141 2150 (Pubitemid 34408463)
51. Nair H. B., Luthra R., Kirma N., Liu Y. G., Flowers L., Evans D., Tekmal R. R., Induction of aromatase expression in cervical carcinomas: effects of endogenous estrogen on cervical cancer cell proliferation Cancer Research 2005 65 23 11164 11173 (Pubitemid 41713388)
52. Mrquez-Garbn D. C., Chen H. W., Goodglick L., Fishbein M. C., Pietras R. J., Targeting aromatase and estrogen signaling in human non-small cell lung cancer Annals of the New York Academy of Sciences 2009 1155 194 205
53. Egloff A. M., Rothstein M. E., Seethala R., Siegfried J. M., Grandis J. R., Stabile L. P., Cross-talk between estrogen receptor and epidermal growth factor receptor in head and neck squamous cell carcinoma Clinical Cancer Research 2009 15 21 6529 6540
54. Stabile L. P., Lyker J. S., Gubish C. T., Zhang W., Grandis J. R., Siegfried J. M., Combined targeting of the estrogen receptor and the epidermal growth factor receptor in non-small cell lung cancer shows enhanced antiproliferative effects Cancer Research 2005 65 4 1459 1470 (Pubitemid 40270175)
55. Hua K., Din J., Cao Q., Feng W., Zhang Y., Yao L., Huang Y., Zhao Y., Feng Y., Estrogen and progestin regulate HIF-1 expression in ovarian cancer cell lines via the activation of Akt signaling transduction pathway Oncology Reports 2009 21 4 893 898
56. Bodily J. M., Mehta K. P.M., Laimins L. A., Human papillomavirus E7 enhances hypoxia-inducible factor 1-mediated transcription by inhibiting binding of histone deacetylases Cancer Research 2011 71 3 1187 1195
57. Mathur R. S., Mathur S. P., Vascular endothelial growth factor (VEGF) up-regulates epidermal growth factor receptor (EGF-R) in cervical cancer in vitro: this action is mediated through HPV-E6 in HPV-positive cancers Gynecologic Oncology 2005 97 1 206 213 (Pubitemid 40403696)
58. Robert F., Blumenschein G., Herbst R. S., Fossella F. V., Tseng J., Saleh M. N., Needle M., Phase I/IIa study of cetuximab with gemcitabine plus carboplatin in patients with chemotherapy-nave advanced non-small-cell lung cancer Journal of Clinical Oncology 2005 23 36 9089 9096
59. Thienelt C. D., Bunn P. A., Hanna N., Rosenberg A., Needle M. N., Long M. E., Gustafson D. L., Kelly K., Multicenter phase I/II study of cetuximab with paclitaxel and carboplatin in untreated patients with stage IV non-small-cell lung cancer Journal of Clinical Oncology 2005 23 34 8786 8793 (Pubitemid 46211524)
60. Kelly K., Herbst R. S., Crowley J. J., Concurrent chemotherapy plus cetuximab or chemotherapy followed by cetuximab in advanced non-small cell lung cancer (NSCLC): a randomized phase II selectional trial SWOG 0342 Journal of Clinical Oncology 2006 l24 18S 7015
61. Kollmannsberger C., Schittenhelm M., Honecker F., Tillner J., Weber D., Oechsle K., Kanz L., Bokemeyer C., A phase I study of the humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody EMD 72000 (matuzumab) in combination with paclitaxel in patients with EGFR-positive advanced non-small-cell lung cancer (NSCLC) Annals of Oncology 2006 17 6 1007 1013 (Pubitemid 43778995)
62. Thatcher N., Chang A., Parikh P., Pereira J. R., Ciuleanu T., Von Pawel J., Thongprasert S., Tan E. H., Pemberton K., Archer V., Carroll K., Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study The Lancet 2005 366 9496 1527 1537 (Pubitemid 41540110)
63. Rinehart J., Adjei A. A., LoRusso P. M., Waterhouse D., Hecht J. R., Natale R. B., Hamid O., Varterasian M., Asbury P., Kaldjian E. P., Gulyas S., Mitchell D. Y., Herrera R., Sebolt-Leopold J. S., Meyer M. B., Multicenter phase II study of the oral MEK inhibitor, CI-1040, in patients with advanced non-small-cell lung, breast, colon, and pancreatic cancer Journal of Clinical Oncology 2004 22 22 4456 4462 (Pubitemid 41185111)
64. Hidalgo M., Buckner J. C., Erlichman C., Pollack M. S., Boni J. P., Dukart G., Marshall B., Speicher L., Moore L., Rowinsky E. K., A phase I and pharmacokinetic study of temsirolimus (CCI-779) administered intravenously daily for 5 days every 2 weeks to patients with advanced cancer Clinical Cancer Research 2006 12 19 5755 5763 (Pubitemid 44629606)